Cause-specific mortality following sustained virologic response in hepatitis C patients treated with direct-acting antivirals: a standardized mortality ratio analysis

Abstract Direct-acting antivirals (DAAs) achieve high sustained virologic response (SVR) rates in patients with hepatitis C virus (HCV) infection. However, the long-term prognosis and cause-specific mortality post-SVR remain unclear. This study analyzed 1753 HCV-infected patients without a history o...

詳細記述

書誌詳細

主要な著者:	Seiichi Mawatari, Shiroh Tanoue, Kotaro Kumagai, Kohei Oda, Ai Toyodome, Haruka Sakae, Kunio Fujisaki, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Kazuaki Tabu, Sho Ijuin, Takeshi Hori, Tsutomu Tamai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-11-01
シリーズ:	Scientific Reports
主題:	HCV DAAs SVR SMR Mortality Cardiovascular disease
オンライン･アクセス:	https://doi.org/10.1038/s41598-025-29972-6
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!